Bath & Body Works (NYSE:BBWI) Price Target Raised to $25.00

Bath & Body Works (NYSE:BBWI) had its price target raised by Telsey Advisory Group from $23.00 to $25.00 in a research note published on Thursday, Marketbeat Ratings reports. Telsey Advisory Group currently has a market perform rating on the stock.

A number of other research analysts also recently weighed in on the stock. Robert W. Baird set a $20.00 price objective on shares of Bath & Body Works in a research report on Wednesday, December 17th. Citigroup cut Bath & Body Works from a “buy” rating to a “neutral” rating and increased their price target for the stock from $21.00 to $25.00 in a report on Tuesday, February 17th. Wells Fargo & Company cut their price target on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, November 21st. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, November 12th. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $18.00 price target (down from $43.00) on shares of Bath & Body Works in a research note on Friday, November 21st. Three analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and an average target price of $24.00.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $20.85 on Thursday. The business has a fifty day moving average price of $22.39 and a 200 day moving average price of $23.47. Bath & Body Works has a 1-year low of $14.27 and a 1-year high of $34.66. The stock has a market capitalization of $4.27 billion, a P/E ratio of 6.62, a price-to-earnings-growth ratio of 2.11 and a beta of 1.48.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.28. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The business had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.59 billion. During the same period in the prior year, the firm posted $2.09 earnings per share. The business’s quarterly revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities research analysts anticipate that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 6th. Shareholders of record on Friday, February 20th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date was Friday, February 20th. Bath & Body Works’s dividend payout ratio is 25.40%.

Hedge Funds Weigh In On Bath & Body Works

Several large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC grew its stake in shares of Bath & Body Works by 132.5% during the 4th quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock valued at $229,834,000 after buying an additional 6,523,960 shares during the period. American Century Companies Inc. grew its holdings in Bath & Body Works by 2,204.1% during the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock worth $133,292,000 after acquiring an additional 4,949,796 shares in the last quarter. Jupiter Asset Management Ltd. increased its holdings in shares of Bath & Body Works by 553.2% in the 3rd quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock valued at $95,685,000 after acquiring an additional 3,145,797 shares during the last quarter. Norges Bank acquired a new stake in Bath & Body Works during the fourth quarter worth about $55,504,000. Finally, Balyasny Asset Management L.P. bought a new stake in Bath & Body Works in the fourth quarter valued at $54,785,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

More Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Company beat Q4 EPS and revenue expectations and outlined a Consumer First growth plan that management says will drive longer‑term improvement. BBWI Beats on Q4 Earnings, Unveils Growth Strategy Amid Soft Demand
• Positive Sentiment: Several analysts raised forecasts and price targets after the quarter (examples: Telsey upped to $25, Deutsche Bank to $22), providing support for upside vs. recent levels. These Analysts Raise Their Forecasts On Bath & Body Works Following Q4 Results
• Positive Sentiment: Several bullish commentary pieces framed BBWI as a deep‑value / turnaround opportunity following the quarter. Bath & Body Works: A Deep Value Opportunity That’s Too Cheap To Ignore
• Neutral Sentiment: Barclays maintained a hold rating (no upgrade), reflecting mixed analyst views on near‑term demand even after the beat. Barclays Sticks to Their Hold Rating for Bath & Body Works (BBWI)
• Neutral Sentiment: Management says the strategic shift is making progress but “will take time,” a cautious tone that tempers the immediate impact of the earnings beat. Bath & Body Works Says Strategy Shift Making Progress But ‘Will Take Time’
• Negative Sentiment: Multiple law firms have filed or are soliciting lead‑plaintiff applicants in a securities class action covering June 4, 2024–Nov 19, 2025, with lead‑plaintiff deadlines in mid‑March — these recurring headlines raise near‑term legal and reputational risk that can pressure the stock. Representative notices: BBWI FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL… The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline… BBWI Investors Have Opportunity to Lead Bath & Body Works Inc Securities Fraud Lawsuit…

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.